|1.||Orjales, Aurelio: 2 articles (12/2003 - 01/2003)|
|2.||La Casa, Carmen: 2 articles (12/2003 - 01/2003)|
|3.||Alarcón de la Lastra, Catalina: 2 articles (12/2003 - 01/2003)|
|4.||Villegas, Isabel: 2 articles (12/2003 - 01/2003)|
01/24/2003 - "Chronic treatment (14 days) with 800 mg/kg/day of dosmalfate also had significant protective effects on TNBS-induced colitis which were reflected by significant attenuation (P<0.05) of the damage score while the inflammatory indicators were not improved. "
01/24/2003 - "These findings confirm the protective effects of dosmalfate in acute and chronic experimental colitis."
12/01/2003 - "In this study, we have evaluated the efficacy of dosmalfate, a new flavonoid derivative compound, for the prevention and treatment of experimental colitis. "
12/01/2003 - "We conclude that dosmalfate is protective in acute DSS-induced colitis. "
12/01/2003 - "(PG)E(2) and (PG)D(2) synthesis were significantly reduced in colitis control group and treatment with dosmalfate abolished the decrease in PG synthesis in colon mucosa. "
|3.||Body Weight (Weight, Body)
|2.||Interleukin-1beta (Interleukin 1 beta)